COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection...

ID 39473011000001103
ConceptGeneric COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials
Name COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials
Abbreviated name COVID-19 Vaccine Nuvaxovid 0.5ml inj multidose vials
Description COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.)
Date of name applicability 23 Feb 2022
Previous Name COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials
SupplierNovavax CZ a.s.
Licensed asMedicines - MHRA/EMA
Previously licensed asNone
License change reasonLicence Granted
Date of change of licensing authority 23 Feb 2022
EMA (European Medicines Agency) Monitoring 1
Restrictions on availabilityRestricted Availability
Licensed routeIntramuscular